Moderna to Host Investor Event - R&D Day and Business Updates

Rhea-AI Summary

Moderna (Nasdaq: MRNA) has announced an upcoming Investor Event - R&D Day and Business Updates scheduled for September 12, 2024 at 9:00 a.m. ET. This event will feature presentations from the company's management team, focusing on Moderna's development and commercial strategy, as well as key business considerations.

Investors and interested parties can access a live webcast of the presentation through the 'Events and Presentations' section of Moderna's investor relations website. For those unable to attend the live event, a replay of the webcast will be available on the company's website for at least 30 days following the presentation, ensuring widespread access to this important corporate update.

News Market Reaction – MRNA

-6.47%

1 alert

-6.47% News Effect

On the day this news was published, MRNA declined 6.47%, reflecting a notable negative market reaction.

Data tracked by StockTitan Argus on the day of publication.

CAMBRIDGE, MA / ACCESSWIRE / August 22, 2024 / Moderna, Inc. (Nasdaq:MRNA) today announced that it will host its Investor Event - R&D Day and Business Updates at 9:00 a.m. ET on Thursday, September 12, 2024.

The event will include presentations from management discussing Moderna's development and commercial strategy and key business considerations. A live webcast of the presentation will be available under "Events and Presentations" in the Investors section of the Moderna website at investors.modernatx.com. A replay of the webcast will be archived on Moderna's website for at least 30 days following the presentation.

About Moderna

Moderna is a leader in the creation of the field of mRNA medicine. Through the advancement of mRNA technology, Moderna is reimagining how medicines are made and transforming how we treat and prevent disease for everyone. By working at the intersection of science, technology and health for more than a decade, the company has developed medicines at unprecedented speed and efficiency, including one of the earliest and most effective COVID-19 vaccines.

Moderna's mRNA platform has enabled the development of therapeutics and vaccines for infectious diseases, immuno-oncology, rare diseases and autoimmune diseases. With a unique culture and a global team driven by the Moderna values and mindsets to responsibly change the future of human health, Moderna strives to deliver the greatest possible impact to people through mRNA medicines. For more information about Moderna, please visit modernatx.com and connect with us on X (formerly Twitter), Facebook, Instagram, YouTube and LinkedIn.

Investors:
Lavina Talukdar
Senior Vice President & Head of Investor Relations
617-209-5834
Lavina.Talukdar@modernatx.com

SOURCE: Moderna, Inc.

View the original press release on accesswire.com

FAQ

When is Moderna's Investor Event - R&D Day scheduled for 2024?

Moderna's Investor Event - R&D Day is scheduled for Thursday, September 12, 2024, at 9:00 a.m. ET.

What topics will be covered during Moderna's (MRNA) 2024 Investor Event?

The event will cover Moderna's development and commercial strategy, as well as key business considerations, presented by the company's management team.

How can investors access Moderna's (MRNA) 2024 R&D Day presentation?

Investors can access a live webcast of the presentation through the 'Events and Presentations' section of Moderna's investor relations website at investors.modernatx.com.

Will there be a replay available for Moderna's (MRNA) 2024 Investor Event?

Yes, a replay of the webcast will be archived on Moderna's website for at least 30 days following the presentation.